Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Scientific Reports|March 23, 2016
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitorsChiara Foglieni, Katiuscia Pagano, Marco Lessi, et al.
Pharmacological Research|April 29, 2026
HIJACKING CLIENT INSTABILITY TO SELECTIVELY DISRUPT HSP90-DRIVEN GLUCOCORTICOID RECEPTOR ACTIVATIONElisa Longhi, Andrea Magni, Luca Torielli, et al.
EMBO Molecular Medicine|June 27, 2018
Soluble stroma-related biomarkers of pancreatic cancerAndrea Resovi, Maria Rosa Bani, Luca Porcu, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 15, 2021
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activityDenise Pinessi, Andrea Resovi, Fabio Sangalli, et al.
Tumori|August 19, 2004
45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003Raffaella Giavazzi, Massimo Aglietta, Annalisa Astolfi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled diseaseSilvia Colucci, Giulia Taraboletti, Luca Primo, et al.
Diabetes|July 7, 2018
ADAMTS13 Deficiency Shortens the Life Span of Mice With Experimental DiabetesPaola Cassis, Domenico Cerullo, Cristina Zanchi, et al.
Angiogenesis|September 1, 2018
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)Marco Rusnati, Patrizia Borsotti, Elisabetta Moroni, et al.
International Journal of Cancer|June 12, 2014
Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1Romina Dossi, Roberta Frapolli, Silvana Di Giandomenico, et al.
The Journal of Biological Chemistry|January 9, 2010
Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compoundsGiorgio Colombo, Barbara Margosio, Laura Ragona, et al.
Pageof 6